CR Ventures
Overview
CR Ventures is a global life-science investor that exclusively invests in companies seeking to fund their clinical trials for pharmaceuticals, diagnostics, and other medical technologies. The firm does not invest in purely pre-clinical rounds and partners with clinical research organizations to support its portfolio companies. It has offices in Boston and Europe.
Portfolio Companies
3
Website
cr-ventures.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bioversys | Jun 2022 | Series C | Co-investor |
| Astrocyte Pharmaceuticals Inc. | May 2021 | Series A | Co-investor |
| Adiposs | Dec 2021 | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is CR Ventures based?
CR Ventures is headquartered in Boston, Massachusetts, United States.
When was CR Ventures founded?
Founding year information for CR Ventures is not publicly available.
How many portfolio companies does CR Ventures have?
CR Ventures has 3 portfolio companies in Caplight's dataset.
What are some companies in CR Ventures's portfolio?
Portfolio companies visible on Caplight include Bioversys, Astrocyte Pharmaceuticals Inc., Adiposs.
What was CR Ventures's most recent investment shown here?
CR Ventures's most recent investment in this portfolio sample was in Bioversys in 2022.
What sectors does CR Ventures focus on?
CR Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does CR Ventures focus on?
CR Ventures typically invests at the Mid stage.